CP Med has released a long sought after product into the medical cannabis market. The first original zkittlez strain to be introduced into the medical market, making its debut in Australia.
‘CPZ’ is being marketed as a high-quality, terpene-rich cannabis product with distinct health benefits of the original Zkittles strain. According to CP Med, the ‘CPZ’ strain stands apart for its unique flavor, profile, and therapeutic effects, offering patients a genuine experience.
Founder Jack of CP Med, has six years of experience in exclusive California cannabis genetics and market, has positioned the company as a player in the space. CP Med focuses on ensuring product consistency for medical cannabis patients.
CP Med has entered into a lifetime exclusive partnership with Dojapak. While the specifics of the partnership are not fully disclosed, it signals the company’s intent to expand its presence in the medical cannabis market. As the industry continues to grow, CP Med’s emphasis on high-quality, authentic cannabis products is helping shape future trends.
For more, CP Medical.
